Metabolic dysregulation in glaucoma DOI
Xuejiao Yang, Songwei Li, Hao Guo

и другие.

Clinical and Experimental Optometry, Год журнала: 2025, Номер unknown, С. 1 - 7

Опубликована: Фев. 12, 2025

Glaucoma is a multifactorial neurodegenerative disorder characterised by the progressive loss of retinal ganglion cells, ultimately leading to irreversible blindness worldwide. Recent research highlights metabolic dysregulation as crucial factor in pathophysiology glaucoma. This review examines intricate relationship between processes and glaucoma, with focus on key mechanisms such mitochondrial dysfunction, lipid metabolism, glucose roles specific metabolites. Mitochondrial dysfunction commonly observed impaired energy production that compromises cellular viability. Alterations including changes fatty acid profiles peroxidation, contribute injury apoptosis cells. Moreover, disturbances reduced glycolytic activity, affect availability neurotrophic support are vital for cells survival. The also explores metabolites, lactate glutamate, context health, how their may exacerbate glaucomatous damage. Additionally, interplay elevated intraocular pressure analysed, particularly regard its impact ocular blood flow health. Understanding these essential identifying potential therapeutic strategies. By deepening our understanding foundations new avenues effective treatments arise, addressing nature this complex disease improving patient outcomes.

Язык: Английский

The Role of Mitophagy in Glaucomatous Neurodegeneration DOI Creative Commons
Dimitrios Stavropoulos,

Manjot Grewal,

Bledi Petriti

и другие.

Cells, Год журнала: 2023, Номер 12(15), С. 1969 - 1969

Опубликована: Июль 30, 2023

This review aims to provide a better understanding of the emerging role mitophagy in glaucomatous neurodegeneration, which is primary cause irreversible blindness worldwide. Increasing evidence from genetic and other experimental studies suggests that mitophagy-related genes are implicated pathogenesis glaucoma various populations. The association between polymorphisms these increased risk presented. Reduction intraocular pressure (IOP) currently only modifiable factor for glaucoma, while clinical trials highlight inadequacy IOP-lowering therapeutic approaches prevent sight loss many patients. Mitochondrial dysfunction thought increase susceptibility retinal ganglion cells (RGCs) factors degeneration. Mitophagy holds vital mitochondrial quality control processes, current explores pathways may be linked their potential.

Язык: Английский

Процитировано

9

Mitochondrial transfer between BMSCs and Müller promotes mitochondrial fusion and suppresses gliosis in degenerative retina DOI Creative Commons
Xiaona Huang,

A Luodan,

Hui Gao

и другие.

iScience, Год журнала: 2024, Номер 27(7), С. 110309 - 110309

Опубликована: Июнь 20, 2024

Mitochondrial dysfunction and Müller cells gliosis are significant pathological characteristics of retinal degeneration (RD) causing blinding. Stem cell therapy is a promising treatment for RD, the recently accepted therapeutic mechanism fusion induced materials transfer. However, whether including mitochondrial transfer between grafted stem recipient's contribute to suppressing unclear. In present study, we demonstrated that bone marrow mesenchymal (BMSCs) transferred mitochondria by tunneling nanotubes. BMSCs-derived (BMSCs-mito) were integrated into network cells, improving function, reducing oxidative stress gliosis, which protected visual function partially in degenerative rat retina. RNA sequencing analysis revealed BMSCs-mito increased DNA (mtDNA) content facilitated damaged cells. It suggests from BMSCs remodels metabolism suppresses gliosis; thus, delaying progression RD.

Язык: Английский

Процитировано

3

Mechanosensitive ion channels in glaucoma pathophysiology DOI
J. García-Sánchez,

Danting Lin,

Wendy W. Liu

и другие.

Vision Research, Год журнала: 2024, Номер 223, С. 108473 - 108473

Опубликована: Авг. 23, 2024

Язык: Английский

Процитировано

3

Differentiation of primary retinal progenitor cells into retinal ganglion-like cells using low dose cytarabine DOI
Baoqi Hu,

Sijia Zhou,

Xiou Wang

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2025, Номер 748, С. 151359 - 151359

Опубликована: Янв. 17, 2025

Язык: Английский

Процитировано

0

Metabolic dysregulation in glaucoma DOI
Xuejiao Yang, Songwei Li, Hao Guo

и другие.

Clinical and Experimental Optometry, Год журнала: 2025, Номер unknown, С. 1 - 7

Опубликована: Фев. 12, 2025

Glaucoma is a multifactorial neurodegenerative disorder characterised by the progressive loss of retinal ganglion cells, ultimately leading to irreversible blindness worldwide. Recent research highlights metabolic dysregulation as crucial factor in pathophysiology glaucoma. This review examines intricate relationship between processes and glaucoma, with focus on key mechanisms such mitochondrial dysfunction, lipid metabolism, glucose roles specific metabolites. Mitochondrial dysfunction commonly observed impaired energy production that compromises cellular viability. Alterations including changes fatty acid profiles peroxidation, contribute injury apoptosis cells. Moreover, disturbances reduced glycolytic activity, affect availability neurotrophic support are vital for cells survival. The also explores metabolites, lactate glutamate, context health, how their may exacerbate glaucomatous damage. Additionally, interplay elevated intraocular pressure analysed, particularly regard its impact ocular blood flow health. Understanding these essential identifying potential therapeutic strategies. By deepening our understanding foundations new avenues effective treatments arise, addressing nature this complex disease improving patient outcomes.

Язык: Английский

Процитировано

0